Seroprevalence of hepatitis C and risk factors in haemodialysis patients in Guilan, Islamic Republic of Iran

Eastern Mediterranean Health Journal

Volumn 11, Issue 3, 2005, Pages 372-376

  Amiri, Z M ^a   Shakib, A J ^a   Toorchi, M ^a  

^a GUILAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

HEPATITIS C ANTIBODY;

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; BLOOD TRANSFUSION; CONFIDENCE INTERVAL; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HEPATITIS C; HEPATITIS C VIRUS; HOSPITAL INFECTION; HUMAN; IMMUNOBLOTTING; INFECTION RISK; IRAN; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; RISK FACTOR; SEROPREVALENCE; SEX; STATISTICAL SIGNIFICANCE; VIRUS TRANSMISSION;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHI-SQUARE DISTRIBUTION; CROSS INFECTION; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; GRAFT REJECTION; HEPATITIS C; HEPATITIS C ANTIBODIES; HUMANS; IMMUNOBLOTTING; INFECTION CONTROL; IRAN; KIDNEY TRANSPLANTATION; MALE; MASS SCREENING; MIDDLE AGED; POPULATION SURVEILLANCE; RENAL DIALYSIS; RISK FACTORS; SEROEPIDEMIOLOGIC STUDIES; TIME FACTORS; URBAN HEALTH;

EID: 33645296559     PISSN: 10203397     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (25)

1. Dienstage JL, Isselbacher KJ. Acute viral hepatitis. In: Fauci AS et al., eds. Harrison's principles of internal medicine, 14th ed. New York, McGraw-Hill, 1999:1686-90.
2. Fallon MB et al. Acute and chronic hepatitis. In: Andreoli TE, Bennett JC, Carpenter CCJ, eds. Cecil essentials of internal medicine, 5th ed. Philadelphia, WB Saunders, 2000:379-83.
3. Thomas DL, Lemon SM. Hepatitis C. In: Mandell GL, Bennett JE, Dolin R, eds. Mandell's principles and practice of infectious diseases, 5th ed. New York, Churchill Livingstone, 2000:1748.
4. Olmer M et al. Transmission of the hepatitis C virus in a hemodialysis unit: evidence for nosocomial infection. Clinical nephrology, 1997, 47(4):263-70.
5. Masuko K et al. Hepatitis C virus antibodies, viral RNA and genotypes in sera from patients on maintenance hemodialysis. Journal of viral hepatitis, 1994, 1(1):65-71.
6. Sampietro M et al. High prevalence of a rare hepatitis C virus in patients treated in the same hemodialysis unit: evidence for nosocomial transmission of HCV. Kidney international, 1995, 47(3):911-7.
7. Sandhu J et al. Hepatitis C prevalence and risk factors in the northern Alberta dialysis population. American journal of epidemiology, 1999, 150(1):58-66.
8. Scotto G et al. Hepatitis C virus infection in four haemodialysis units of southern Italy: epidemiological report. European journal of epidemiology, 1999, 15(3): 217-23.
9. Grethe S et al. Molecular epidemiology of an outbreak of HCV in a hemodialysis unit: direct sequencing of HCV-HVR1 as an appropriate tool for phylogenetic analysis. Journal of medical virology, 2000, 60(2):152-8.
10. Cialdea L, Sagliocca L, Mele A. Epidemiologia e prevenzione dell'infe-zione da HCV nei centri di dialisi [Epidemiology and prevention of HCV infection in dialysis centers]. Annali dell'Istituto superiore di sanità, 1995, 31(3):313-5.
11. Pru CE et al. Transmission through dialysis machine. ASAIO journal, 1994, 40(3): 889-91.
12. Dos-Santos JP et al. Impact of dialysis room and reuse strategies on the incidence of HCV infection in haemodialysis units. Nephrology, dialysis, transplantation, 1996, 11(10):2017-22.
13. Hou CH et al. Intrafamilial transmission of HCV in hemodialysis patients. Journal of medical virology, 1995, 45(4):381-5.
14. Periera BJ et al. The impact of pretransplantation HCV infection on the outcome of renal transplant. Transplantation, 1995, 60(8):799-805.
15. Furusyo N et al. Maintenance hemodialysis decreases serum hepatitis C virus (HCV) RNA levels in hemodialysis patients with chronic HCV infection. American journal of gastroenterology, 2000, 95(2):490-6.
16. Hayashi J et al. Prevalence of antibody to hepatitis C virus in hemodialysis patients. American journal of epidemiology, 1991, 134(6):651-7.
17. Hung K-Y et al. Hepatitis B and C in hemodialysis patients. Dialysis & transplantation, 1995, 24(3):135-8.
18. El Gohary A et al. High prevalence of hepatitis C virus among urban and rural population groups in Egypt. Acta tropica, 1995, 59(2):155-61.
19. Nowbakht-Haghighi A, Nowroozi A. [Hepatitis C prevalence and risk factors in hemodialysis patients in Tehran]. Pejouhandeh quarterly research journal, 1997, 2(2):13-17 [in Farsi].
20. Saffar MJ, Salehi A. [Prevalence of hepatitis C virus infection in hemodialysis patients in Mazandaran province (Iran)]. Mazandaran University of Medical Sciences journal, 1998, 21:39-49 [in Farsi].
21. Ebrahim-Poor S, Hashemi SN, Kooshavar H. [Prevalence of hepatitis C virus infection in diabetic and hemodialysis patients in Tabriz (Iran)]. Tabriz University of Medical Sciences journal, 1999, 33(44):3-8 [in Farsi].
22. Mecvandi M et al. [Prevalence of anti-HCV antibody in hemodialysis patients in Ahwaz (Iran)]. Ahwaz University of Medical Sciences journal, 2000, 29:1-5 [in Farsij.
23. Ansar MM, Kooloobandi A. Prevalence of hepatitis C virus infection in thalassemia and hemodialysis patients in north Iran - Rasht. Journal of viral hepatitis, 2002, 9(5):390-2.
24. Bald S et al. Renal disease associated with hepatitis C infection after kidney and liver transplantation. Transplantation, 2000, 70(2):255-61.
25. Legendre C et al. Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients. Transplantation, 1998, 65(5):667-70.